Co-Diagnostics Gets EUA From FDA For Logix Smart COVID-19 Test - Quick Facts

Molecular diagnostics company Co-Diagnostics, Inc. (CODX) announced Monday that its Logix Smart coronavirus COVID-19 test has obtained Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to be used for the diagnosis of SARS-CoV-2.

from RTT - Biotech https://ift.tt/2Vasw4u
via IFTTT